|
US20070014787A1
(en)
*
|
1998-07-15 |
2007-01-18 |
Human Genome Sciences, Inc. |
71 human secreted proteins
|
|
US7479555B2
(en)
|
1999-07-21 |
2009-01-20 |
Ceres, Inc. |
Polynucleotides having a nucleotide sequence that encodes a polypeptide having MOV34 family activity
|
|
US8044259B2
(en)
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
|
US6984522B2
(en)
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
|
US7534429B2
(en)
|
2000-11-29 |
2009-05-19 |
Hoffmann-La Roche Inc. |
Cytotoxicity mediation of cells evidencing surface expression of CD63
|
|
US7431923B2
(en)
|
2005-01-03 |
2008-10-07 |
Arius Research Inc. |
Cytotoxicity mediation of cells evidencing surface expression of CD63
|
|
US7442777B2
(en)
|
2000-11-29 |
2008-10-28 |
Arius Research Inc. |
Cytotoxicity mediation of cells evidencing surface expression of CD63
|
|
AU2002332929A1
(en)
|
2001-09-07 |
2003-03-24 |
Bristol-Myers Squibb Company |
Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy39
|
|
WO2004013311A2
(en)
*
|
2002-08-06 |
2004-02-12 |
Diadexus, Inc. |
Compositions and methods relating to ovarian specific genes and proteins
|
|
US20050037946A1
(en)
*
|
2003-01-13 |
2005-02-17 |
Millennium Pharmaceuticals, Inc. |
Methods and compositions for treating cardiovascular disease using 1722, 10280, 59917, 85553, 10653, 9235, 21668, 17794, 2210, 6169, 10102, 21061, 17662, 1468, 12282, 6350, 9035, 1820, 23652, 7301, 8925, 8701, 3533, 9462, 9123, 12788, 17729, 65552, 1261, 21476, 33770, 9380, 2569654, 33556, 53656, 44143, 32612, 10671, 261, 44570, 41922, 2552, 2417, 19319, 43969, 8921, 8993, 955, 32345, 966, 1920, 17318, 1510, 14180, 26005, 554, 16408, 42028, 112091, 13886, 13942, 1673, 54946 or 2419
|
|
WO2004083388A2
(en)
|
2003-03-14 |
2004-09-30 |
Bristol-Myers Squibb Company |
Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
|
|
ITRM20030149A1
(it)
|
2003-04-02 |
2004-10-03 |
Giuliani Spa |
Oligonucleotidi (odn) antisenso per smad7 e loro usi in campo medico
|
|
WO2005019258A2
(en)
*
|
2003-08-11 |
2005-03-03 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
US20050186577A1
(en)
|
2004-02-20 |
2005-08-25 |
Yixin Wang |
Breast cancer prognostics
|
|
US7306923B2
(en)
*
|
2004-06-14 |
2007-12-11 |
Galapagos N.V. |
Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases
|
|
CA2570483A1
(en)
*
|
2004-06-21 |
2006-01-05 |
Exelixis, Inc. |
Pgds as modifiers of the pten pathway and methods of use
|
|
JPWO2006006477A1
(ja)
*
|
2004-07-09 |
2008-04-24 |
国立大学法人三重大学 |
骨疾患又は関節疾患に関与するポリペプチド及びそのｄｎａ
|
|
EP1768690A4
(en)
*
|
2004-07-16 |
2009-09-09 |
Val Chum S E C |
METHODS OF USING NUCLEAR ANTIGEN OF LAMIN B1, FRAGMENTS AND COMPOSITIONS THEREOF TO PREVENT OR TREAT A THROMBOTIC EVENT
|
|
EP1835933A4
(en)
*
|
2005-01-04 |
2015-01-07 |
Yeda Res & Dev |
HSP60, HSP60-PEPTIDES AND T-CELL VACCINES FOR IMMUNOMODULATION
|
|
AU2006216715A1
(en)
|
2005-02-22 |
2006-08-31 |
Ceres Inc. |
Modulating plant alkaloids
|
|
EP1851543A2
(en)
|
2005-02-24 |
2007-11-07 |
Compugen Ltd. |
Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
|
|
GB0510627D0
(en)
|
2005-05-25 |
2005-06-29 |
Avidex Ltd |
Polypeptides
|
|
US8124839B2
(en)
|
2005-06-08 |
2012-02-28 |
Ceres, Inc. |
Identification of terpenoid-biosynthesis related regulatory protein-regulatory region associations
|
|
EP1926747A1
(en)
*
|
2005-08-12 |
2008-06-04 |
Schering Corporation |
Mcp1 fusions
|
|
GB0519376D0
(en)
*
|
2005-09-23 |
2005-11-02 |
Astrazeneca Ab |
Diagnostic method
|
|
US8110184B2
(en)
*
|
2005-09-30 |
2012-02-07 |
University Of Kentucky Research Foundation |
Ex vivo and in vivo methods and related compositions for generating hematopoietic stem cell populations
|
|
AU2006308847C1
(en)
|
2005-10-31 |
2012-05-10 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for treating and diagnosing cancer
|
|
US20070192885A1
(en)
*
|
2006-01-26 |
2007-08-16 |
Daniel Chelsky |
TAT-039 and methods of assessing and treating cancer
|
|
US8252547B2
(en)
|
2006-03-20 |
2012-08-28 |
Japan Science And Technology Agency |
In vitro control of protein synthesis in mammalian cells by IP3 receptor-binding protein
|
|
JP5146944B2
(ja)
*
|
2006-03-20 |
2013-02-20 |
独立行政法人理化学研究所 |
Ｉｐ３受容体結合タンパク質による細胞内標的分子の制御
|
|
EP2006380A4
(en)
|
2006-03-23 |
2010-08-11 |
Kyowa Hakko Kirin Co Ltd |
AGONIST ANTIBODY AGAINST THE HUMAN THROMBOPOIETINE RECEPTOR
|
|
US20070237713A1
(en)
|
2006-04-04 |
2007-10-11 |
Fan Rong A |
PCan065 Antibody Compositions and Methods of Use
|
|
PL2032166T3
(pl)
*
|
2006-06-13 |
2013-09-30 |
Oncomed Pharm Inc |
Kompozycje i sposoby diagnozowania i leczenia nowotworów
|
|
JP4997547B2
(ja)
*
|
2006-06-15 |
2012-08-08 |
独立行政法人理化学研究所 |
炎症性疾患の判定方法
|
|
FR2908654B1
(fr)
|
2006-11-20 |
2014-04-04 |
Oreal |
Utilisation cosmetique de proteines de type chitinase
|
|
EP2097138A2
(en)
*
|
2006-11-29 |
2009-09-09 |
Medical Research Council |
Assay
|
|
WO2008079406A2
(en)
*
|
2006-12-19 |
2008-07-03 |
Genentech, Inc. |
Gene expression markers for inflammatory bowel disease
|
|
EP2106439B1
(en)
|
2007-01-24 |
2014-11-12 |
The Regents of the University of Michigan |
Compositions and methods for treating and diagnosing pancreatic cancer
|
|
JP5618544B2
(ja)
|
2007-01-24 |
2014-11-05 |
オンコメッドファーマシューティカルズ インコーポレイテッド |
癌の診断および処置のための組成物および方法
|
|
WO2008092214A1
(en)
*
|
2007-02-02 |
2008-08-07 |
Minomic International Limited |
Biomarkers for diabetes
|
|
US20090208491A1
(en)
*
|
2007-02-14 |
2009-08-20 |
Austin Gurney |
Compositions and Methods for Diagnosing and Treating Cancer
|
|
JP5378202B2
(ja)
*
|
2007-03-15 |
2013-12-25 |
株式会社リバース・プロテオミクス研究所 |
脳・神経に特異的あるいは神経分化に特異的なバイオマーカー
|
|
US8545888B2
(en)
*
|
2007-06-14 |
2013-10-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Tendon stem cells
|
|
CN101835799A
(zh)
*
|
2007-08-24 |
2010-09-15 |
麦莱克萨有限公司 |
超敏反应调节剂
|
|
JP2009055838A
(ja)
*
|
2007-08-31 |
2009-03-19 |
Nipro Corp |
融合タンパク質、該融合タンパク質に関連する遺伝子、ベクター、形質転換体及び抗炎症性医薬組成物
|
|
JOP20190083A1
(ar)
|
2008-06-04 |
2017-06-16 |
Amgen Inc |
بولي ببتيدات اندماجية طافرة لـfgf21 واستخداماتها
|
|
US9132189B2
(en)
|
2008-07-08 |
2015-09-15 |
Oncomed Pharmaceuticals, Inc. |
Notch1 binding agents and methods of use thereof
|
|
US8834875B2
(en)
|
2010-01-13 |
2014-09-16 |
Oncomed Pharmaceuticals, Inc. |
Notch1 binding agents and methods of use thereof
|
|
CN102316897B
(zh)
|
2008-07-08 |
2014-11-05 |
昂考梅德药品有限公司 |
Notch结合剂和拮抗剂及其应用方法
|
|
EP2358749B1
(en)
|
2008-10-10 |
2018-07-18 |
Amgen, Inc |
Fgf21 mutants and uses thereof
|
|
AU2009308707A1
(en)
|
2008-10-31 |
2010-05-06 |
Biogen Idec Ma Inc. |
LIGHT targeting molecules and uses thereof
|
|
RU2520748C2
(ru)
*
|
2008-12-04 |
2014-06-27 |
Санофи |
Способы и применения, включающие гемсвязывающий белок 1
|
|
WO2010067308A2
(en)
|
2008-12-08 |
2010-06-17 |
Compugen Ltd. |
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
|
|
BRPI1011404B1
(pt)
|
2009-05-05 |
2022-05-03 |
Amgen Inc |
Polipeptídeos mutantes fgf21, polipeptídeo de fusão, multímero, composição farmacêutica, ácido nucleico isolado, vetor e célula hospedeira
|
|
AU2010246038A1
(en)
|
2009-05-05 |
2011-12-01 |
Amgen Inc. |
FGF21 mutants and uses thereof
|
|
WO2010129890A2
(en)
*
|
2009-05-08 |
2010-11-11 |
Virginia Tech Intellectual Properties, Inc. |
Compounds and methods for inhibiting platelet aggregation
|
|
WO2010141999A1
(en)
*
|
2009-06-12 |
2010-12-16 |
The University Of Queensland |
Agents and methods for diagnosing and treating ankylosing spondylitis
|
|
EP2443145A1
(en)
|
2009-06-17 |
2012-04-25 |
Amgen, Inc |
Chimeric fgf19 polypeptides and uses thereof
|
|
WO2011053982A2
(en)
|
2009-11-02 |
2011-05-05 |
University Of Washington |
Therapeutic nuclease compositions and methods
|
|
JP2013512672A
(ja)
*
|
2009-12-02 |
2013-04-18 |
アムジエン・インコーポレーテツド |
ヒトＦＧＦＲ１ｃ、ヒトβ−クロト−、ならびにヒトＦＧＦＲ１ｃおよびヒトβ−クロト−の両方に結合する結合タンパク質
|
|
UA109888C2
(uk)
*
|
2009-12-07 |
2015-10-26 |
|
ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
|
|
EP2517049B1
(en)
|
2010-01-28 |
2014-01-08 |
Canon Kabushiki Kaisha |
Scintillator crystal body, method for manufacturing the same, and radiation detector
|
|
CA2695337A1
(en)
*
|
2010-03-04 |
2011-09-04 |
Ian De Belle |
Compositions and methods for inhibition of hiv
|
|
US8524217B2
(en)
|
2010-05-11 |
2013-09-03 |
Merck Sharp & Dohme Corp. |
MCP1-Ig fusion variants
|
|
EP2975134A3
(en)
|
2010-07-22 |
2016-02-24 |
Shire Human Genetic Therapies, Inc. |
Crystal structure of human alpha-n-acetylglucosaminidase
|
|
KR101650995B1
(ko)
|
2010-11-08 |
2016-08-25 |
노파르티스 아게 |
Ｃｘｃｒ２ 결합 폴리펩티드
|
|
IT1406405B1
(it)
*
|
2010-12-27 |
2014-02-21 |
Univ Roma |
Molecole peptidiche per il trattamento di patologie mitocondriali
|
|
WO2012090150A2
(en)
*
|
2010-12-27 |
2012-07-05 |
Compugen Ltd |
New cell-penetrating peptides and uses thereof
|
|
JP6063450B2
(ja)
|
2011-04-29 |
2017-01-18 |
ユニヴァーシティ オブ ワシントン |
治療用ヌクレアーゼ組成物および方法
|
|
US20150133322A1
(en)
*
|
2011-05-13 |
2015-05-14 |
Inserm (Institut National De La Sante Et De La Recherche Medicale |
Method for the diagnosis of early rheumatoid arthritis
|
|
US9328174B2
(en)
|
2012-05-09 |
2016-05-03 |
Novartis Ag |
Chemokine receptor binding polypeptides
|
|
BR112015010436A2
(pt)
|
2012-11-07 |
2017-08-22 |
Pfizer |
Anticorpos anti-notch3 e conjugados anticorpo-fármaco
|
|
WO2014100689A1
(en)
|
2012-12-21 |
2014-06-26 |
Aveo Pharmaceuticals, Inc. |
Anti-gdf15 antibodies
|
|
US9944700B2
(en)
|
2013-03-13 |
2018-04-17 |
Novartis Ag |
Notch2 binding molecules for treating respiratory diseases
|
|
HRP20192080T1
(hr)
|
2013-10-31 |
2020-02-07 |
Resolve Therapeutics, Llc |
Terapeutske fuzije nukleaza-albumine i postupci
|
|
RU2016128557A
(ru)
*
|
2013-12-29 |
2018-02-01 |
Кьюрлаб Онколоджи, Инк. |
МЕТОДЫ И КОМПОЗИЦИИ, СВЯЗАННЫЕ С p62 / SQSTM1, ДЛЯ ЛЕЧЕНИЯ И ПРОФИЛАКТИКИ ЗАБОЛЕВАНИЙ, АССОЦИИРОВАННЫХ С ВОСПАЛЕНИЕМ
|
|
WO2015158006A1
(zh)
*
|
2014-04-18 |
2015-10-22 |
烟台聚杰生物工程有限公司 |
15种男性生育相关蛋白或其组合的应用
|
|
SG11201700901SA
(en)
|
2014-08-08 |
2017-03-30 |
Alector Llc |
Anti-trem2 antibodies and methods of use thereof
|
|
GB201508025D0
(en)
|
2015-05-11 |
2015-06-24 |
Ucl Business Plc |
Fabry disease gene therapy
|
|
BR112018071686A2
(pt)
*
|
2016-04-22 |
2019-02-19 |
Vaccinex, Inc. |
exibição de proteínas integrais de membrana em vírions extracelulares envelopados de poxvírus
|
|
DK3478830T3
(da)
|
2016-07-01 |
2024-05-21 |
Resolve Therapeutics Llc |
Optimerede binucleasefusioner og metoder
|
|
KR102033215B1
(ko)
*
|
2016-07-05 |
2019-10-16 |
성균관대학교산학협력단 |
건선 유발 동물 모델 및 이의 용도
|
|
GB201700567D0
(en)
|
2017-01-12 |
2017-03-01 |
Genagon Therapeutics Ab |
Therapeutic agents
|
|
US11629340B2
(en)
|
2017-03-03 |
2023-04-18 |
Obsidian Therapeutics, Inc. |
DHFR tunable protein regulation
|
|
BR112019024750A2
(pt)
*
|
2017-05-24 |
2020-06-09 |
Thoeris Gmbh |
uso de glutamina sintetase no tratamento da hiperamonemia
|
|
HRP20230675T1
(hr)
|
2017-08-03 |
2023-09-29 |
Alector Llc |
Anti-trem2 protutijela i postupci njihove uporabe
|
|
JP7374091B2
(ja)
|
2017-08-22 |
2023-11-06 |
サナバイオ， エルエルシー |
可溶性インターフェロン受容体およびその使用
|
|
US12274733B2
(en)
|
2018-09-28 |
2025-04-15 |
President And Fellows Of Harvard College |
Cellular reprogramming to reverse aging and promote organ and tissue regeneration
|
|
AU2019347666B2
(en)
|
2018-09-28 |
2025-10-02 |
President And Fellows Of Harvard College |
Cellular reprogramming to reverse aging and promote organ and tissue regeneration
|
|
US20210388345A1
(en)
*
|
2018-10-22 |
2021-12-16 |
Roche Sequencing Solutions, Inc. |
Profiling of rheumatoid arthritis autoantibody repertoire and peptide classifiers therefor
|
|
WO2020178426A1
(en)
*
|
2019-03-07 |
2020-09-10 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New vaccinal strategy to prevent or treat rheumatoid arthritis
|
|
CN115698048A
(zh)
*
|
2020-01-21 |
2023-02-03 |
勃林格殷格翰国际有限公司 |
用于治疗或预防纤维化、肥大或心力衰竭的髓源性生长因子
|
|
US20250270278A1
(en)
*
|
2020-12-07 |
2025-08-28 |
The Research Foundation For The State University Of New York |
Methods of making water-soluble protein formed in a bacterial expression system, compositions, and methods of use thereof
|
|
US12252518B2
(en)
|
2023-01-06 |
2025-03-18 |
Life Biosciences, Inc. |
Methods of treating non-arteritic anterior ischemic optic neuropathy
|
|
WO2024231931A1
(en)
*
|
2023-05-08 |
2024-11-14 |
Canopy Immuno-Therapeutics Ltd. |
Ig-like fusion proteins for treating immune thrombocytopenia
|
|
US20250108088A1
(en)
*
|
2023-10-02 |
2025-04-03 |
Matice BioSciences, Inc. |
Regenerative peptides and methods for use thereof
|